mecImpactReport 2022 v1.7 lr pages - Flipbook - Page 23
23
We work with Moorfields to shape national policy and increase
resources allocated to eye health. We collaborate with other
charities and funders. We use our knowledge and expertise
to influence national policies, and we mobilise supporters and
partners to raise awareness and contribute as influencers.
Government funding boost to research
We are members of the
Association of Medical
Research Charities (AMRC)
and contributed to its
#ResearchAtRisk campaign
which called for more
investment in medical
research charities. Whilst
the Government has not yet
responded with specific funding
at the levels which AMRC
and its members consider
appropriate, the 2021 Spending
Review and Budget committed
record levels of investment in
the UK’s research base over
the next three years, with
research and development
spending set to increase by £5
billion to £20 billion per annum
by 2024-2025.
A significant proportion of the
budget has been allocated to
UK Research and Innovation
(UKRI), which will receive over
£25 billion across the next
three years, reaching over
£8.8 billion in 2024-2025, its
highest ever level and over £1
billion more than in 2021-2022.
This will have a significant
impact on opportunities for
the world-renowned research
partnership that is Moorfields
and UCL now and into the
future.
Research and
development spending
set to increase to £20
billion by 2024-2025
Sustained investment is so important for research
which, by its very nature, takes time. What we think of as
overnight cures come from years of prior hard work, effort
and funding. This Government commitment is a positive
signal about the importance of R&D to the UK’s economy.
Medical research charities, industry and the public sector are
all vital cogs in the complicated network of research funding.
Let’s keep them strong and able to deliver what we all need
to stay as healthy as possible for as long as possible.
Nicola Perrin, Chief executive of the Association of Medical
Research Charities
This sends an important message about the value
of research and development and its impact on patients,
including those with sight loss who will benefit from the
advances in medicine. This long-term investment will also
impact on Oriel and the future of eye health, bringing new
discoveries to the people who need them speedily and
safely.
Robert Dufton, Chief executive, Moorfields Eye Charity
UKRI to receive over
£25 billion across the
next three years